CLOs on the Move

Insight Imaging

www.insighthealth.com

 
Insight Imaging is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Illinois State Medical Society

Illinois State Medical Society is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Government Scientific Source, Inc.

Government Scientific Source, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Reston, VA. To find more information about Government Scientific Source, Inc., please visit www.govsci.com

Cunningham Drug Co Inc

Cunningham Drug Co Inc is a New Tazewell, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Morehead Memorial Hospital

Morehead Memorial Hospital operates as a community hospital that provides various medical services to patients in Eden, North Carolina. It offers birthing center, cancer center, cardiac rehabilitation and chronic disease management, cardiopulmonary, day hospital, diagnostic imaging, emergency, intensive coronary care unit, laboratory, nursing center, occupational health, rehabilitation, sleep center, diagnostic center, wound healing center, and women’s diagnostic services. The company was founded in 1960 and is headquartered in Eden, North Carolina.

Bioatla

BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.